|
|
Review of hand, foot and mouth disease |
Lan-Juan LI MD, |
State Key Laboratory
for Diagnosis and Treatment of Infectious Diseases, The First Affiliated
Hospital, College of Medicine, Zhejiang University, Hangzhou 310003,
China; |
|
|
Abstract Hand, foot and mouth disease (HFMD) is an acute viral illness that primarily affects infants and young children, and often occurs in clusters or outbreaks. The major causative agents of HFMD are coxsackievirus A16 (CVA16), human enterovirus 71 (HEV71) and coxsackievirus A10 (CVA10), of the genus Enterovirus in the family Picornaviridae. HFMD caused by EV71 is associated with severe neurological complications and death. Since the late 1990s, several major epidemics of EV71 HFMD have swept through the Asia-Pacific region, associated with a rapid fulminant course, severe neurological complications, and a large number of fatalities. Until now, little has been known about the genetics and transmission trends of the fast-mutation virus, and there is no effective and specific antiviral therapy or vaccine for HFMD. It is time to step up efforts to understand the molecular epidemics and pathogenesis so that we can develop effective management strategies and surveillance programs.
|
Keywords
hand, foot and mouth disease
epidemiology
pathogenesis
management
surveillance
|
Issue Date: 05 June 2010
|
|
|
Yan J J, Su I J, Chen P F, Liu C C, Yu C K, Wang J R. Complete genome analysis of enterovirus 71 isolated froman outbreak in Taiwan and rapid identification of enterovirus 71 andcoxsackievirus A16 by RT-PCR. J Med Virol, 2001, 65(2): 331–339
doi: 10.1002/jmv.2038
|
|
Bible J M, Pantelidis P, Chan P K, Tong C Y. Genetic evolution of enterovirus 71: epidemiologicaland pathological implications. Rev Med Virol, 2007, 17(6): 371–379
doi: 10.1002/rmv.538
|
|
Schmidt N J, Lennette E H, Ho H H. An apparently new enterovirusisolated from patients with disease of the central nervous system. J Infect Dis, 1974, 129(3): 304–309
|
|
Deibel R, Gross L L, Collins D N. Isolation of a new enterovirus (38506). Proc Soc Exp Biol Med, 1975, 148(1): 203–207
|
|
Blomberg J, Lycke E, Ahlfors K, Johnsson T, Wolontis S, von Zeipel G. Letter: New enterovirus type associated with epidemicof aseptic meningitis and-or hand, foot, and mouth disease. Lancet, 1974, 2(7872): 112
doi: 10.1016/S0140-6736(74)91684-5
|
|
Tagaya I, Tachibana K. Epidemic of hand, foot and mouth disease in Japan, 1972―1973: differencein epidemiologic and virologic features from the previous one. Jpn J Med Sci Biol, 1975, 28(4): 231–234
|
|
Gilbert G L, Dickson K E, Waters M J, Kennett M L, Land S A, Sneddon M. Outbreak of enterovirus 71 infectionin Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J, 1988, 7(7): 484–488
doi: 10.1097/00006454-198807000-00007
|
|
Shindarov L M, Chumakov M P, Voroshilova M K, Bojinov S, Vasilenko S M, Iordanov I, Kirov I D, Kamenov E, Leshchinskaya E V, Mitov G, Robinson I A, Sivchev S, Staikov S. Epidemiological, clinical, and pathomorphological characteristicsof epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol, 1979, 23(3): 284–295
|
|
Nagy G, Takatsy S, Kukan E, Mihaly I, Domok I. Virological diagnosis of enterovirus type 71 infections: experiences gained duringan epidemic of acute CNS diseases in Hungary in 1978. Arch Virol, 1982, 71(3): 217–227
doi: 10.1007/BF01314873
|
|
World Health Organization. Outbreak of hand, foot and mouth disease in Sarawak.Cluster of deaths among infants and young children. Wkly Epidemiol Rec, 1997, 72(28): 211–212
|
|
Lin T Y, Chang L Y, Hsia S H, Huang Y C, Chiu C H, Hsueh C, Shih S R, Liu C C, Wu M H. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis, 2002, 34 Suppl 2: S52–57
doi: 10.1086/338819
|
|
Shimizu H, Utama A, Onnimala N, Li C, Li-Bi Z, Yu-Jie M, Pongsuwanna Y, Miyamura T. Molecular epidemiology ofenterovirus 71 infection in the Western Pacific Region. Pediatr Int, 2004, 46(2): 231–235
doi: 10.1046/j.1442-200x.2004.01868.x
|
|
AbuBakar S, Chee H Y, Al-Kobaisi M F, Xiaoshan J, Chua K B, Lam S K. Identification of enterovirus 71 isolatesfrom an outbreak of hand, foot and mouth disease (HFMD) with fatalcases of encephalomyelitis in Malaysia. Virus Res, 1999, 61(1): 1–9
doi: 10.1016/S0168-1702(99)00019-2
|
|
Lum L C, Wong K T, Lam S K, Chua K B, Goh A Y, Lim W L, Ong B B, Paul G, AbuBakar S, Lambert M. Fatal enterovirus 71 encephalomyelitis, J Pediatr, 1998, 133(6): 795–798
doi: 10.1016/S0022-3476(98)70155-6
|
|
Qiu J. Viral outbreak in China tests government efforts. Nature, 2009, 458(7238): 554–555
doi: 10.1038/458554a
|
|
Li L, He Y, Yang H, Zhu J, Xu X, Dong J, Zhu Y, Jin Q. Genetic characteristics of human enterovirus71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen,people's Republic of China. J Clin Microbiol, 2005, 43(8): 3835–3839
doi: 10.1128/JCM.43.8.3835-3839.2005
|
|
Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, He Y, Bu G, Zhou S, Wang J, Qi J. Enterovirus 71 outbreak in the people's Republic of China in 2008. J Clin Microbiol, 2009, 47(7): 2351–2352
doi: 10.1128/JCM.00563-09
|
|
http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohbgt/s3582/200903/39757.htm
|
|
http://gov.rednet.cn/c/2009/04/10/1742172.htm (in Chinese)
|
|
Brown B A, Oberste M S, Alexander J P Jr, Kennett M L, Pallansch M A. Molecular epidemiology and evolution of enterovirus 71 strains isolatedfrom 1970 to 1998. J Virol, 1999, 73(12): 9969–9975
|
|
McMinn P, Lindsay K, Perera D, Chan H M, Chan K P, Cardosa M J. Phylogenetic analysis of enterovirus71 strains isolated during linked epidemics in Malaysia, Singapore,and Western Australia. J Virol, 2001, 75(16): 7732–7738
doi: 10.1128/JVI.75.16.7732-7738.2001
|
|
Tong C, Bible J. Global epidemiology of Enterovirus 71. Future Virol, 2009, 4(5): 501–510
doi: 10.2217/fvl.09.25
|
|
Zhang Y, Tan X J, Wang H Y, Yan D M, Zhu S L, Wang D Y, Ji F, Wang X J, Gao Y J, Chen L, An H Q, Li D X, Wang S W, Xu A Q, Wang Z J, Xu W B. An outbreak of hand, foot, and mouth disease associatedwith subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol, 2009, 44(4): 262–267
doi: 10.1016/j.jcv.2009.02.002
|
|
Huang S C, Hsu Y W, Wang H C, Huang S W, Kiang D, Tsai H P, Wang S M, Liu C C, Lin K H, Su I J, Wang J R. Appearance of intratypic recombination of enterovirus71 in Taiwan from 2002 to 2005. Virus Res, 2008, 131(2): 250–259
doi: 10.1016/j.virusres.2007.10.002
|
|
Yoke-Fun C, AbuBakar S. Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus71 subgenotypes. BMC Microbiol, 2006, 6: 74
doi: 10.1186/1471-2180-6-74
|
|
Ding N Z, Wang X M, Sun S W, Song Q, Li S N, He C Q. Appearance of mosaic enterovirus 71 in the 2008 outbreakof China. Virus Res, 2009, 145(1): 157–161
doi: 10.1016/j.virusres.2009.06.006
|
|
Ho H Y, Cheng M L, Weng S F, Chang L, Yeh T T, Shih S R, Chiu D T. Glucose-6-phosphatedehydrogenase deficiency enhances enterovirus 71 infection. J Gen Virol, 2008, 89(Pt 9): 2080–2089
doi: 10.1099/vir.0.2008/001404-0
|
|
Chang L Y, Chang I S, Chen W J, Huang Y C, Chen G W, Shih S R, Juang J L, Shih H M, Hsiung C A, Lin T Y, Huang L M. HLA-A33 is associated with susceptibility to enterovirus71 infection. Pediatrics, 2008, 122(6): 1271–1276
doi: 10.1542/peds.2007-3735
|
|
Huemer H P, Ortner B, Huang C W, Schmid D, Mutz I, Wewalka G, Yang J Y, Allerberger F. Isolating Asian enterovirus71 subgenogroup C4 in two Austrian clinical samples from 2004. Euro Surveill, 2008, 13(28): pii: 18922
|
|
Zhang Y, Tan X J, Wang H Y, Yan D M, Zhu S L, Wang D Y, Ji F, Wang X J, Gao Y J, Chen L, An H Q, Li D X, Wang S W, Xu A Q, Wang Z J, Xu W B. An outbreak of hand, foot, and mouth disease associatedwith subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol, 2009, 44(4): 262–267
doi: 10.1016/j.jcv.2009.02.002
|
|
Qiu J. Enterovirus 71 infection: a new threat to global publichealth? Lancet Neurol, 2008, 7(10): 868–869
doi: 10.1016/S1474-4422(08)70207-2
|
|
Chen L C, Shyu H W, Chen S H, Lei H Y, Yu C K, Yeh T M. Enterovirus 71 infection induces Fas ligand expressionand apoptosis of Jurkat cells. J Med Virol, 2006, 78(6): 780–786
doi: 10.1002/jmv.20623
|
|
Chang S C, Lin J Y, Lo L Y, Li M L, Shih S R. Diverse apoptotic pathwaysin enterovirus 71-infected cells. J Neurovirol, 2004, 10(6): 338–349
doi: 10.1080/13550280490521032
|
|
Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus71. Nat Med, 2009, 15(7): 798–801
doi: 10.1038/nm.1992
|
|
Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoproteinligand-1 is a functional receptor for enterovirus 71. Nat Med, 2009, 15(7): 794–797
doi: 10.1038/nm.1961
|
|
Lin T Y, Chang L Y, Hsia S H, Huang Y C, Chiu C H, Hsueh C, Shih S R, Liu C C, Wu M H. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis, 2002, 34 (Suppl 2): S52–57
doi: 10.1086/338819
|
|
Chang L Y, Hsia S H, Wu C T, Huang Y C, Lin K L, Fang T Y, Lin T Y. Outcome of enterovirus 71 infections with or without stage-based management:1998 to 2002. Pediatr Infect Dis J, 2004, 23(4): 327–332
doi: 10.1097/00006454-200404000-00010
|
|
Chang L Y, Lin T Y, Hsu K H, Huang Y C, Lin K L, Hsueh C, Shih S R, Ning H C, Hwang M S, Wang H S, Lee C Y. Clinical features and risk factors of pulmonary oedemaafter enterovirus-71-related hand, foot, and mouth disease. Lancet, 1999; 354(9191): 1682–1686
doi: 10.1016/S0140-6736(99)04434-7
|
|
Wang S M, Lei H Y, Huang M C, Su L Y, Lin H C, Yu C K, Wang J L, Liu C C. Modulation of cytokine production byintravenous immunoglobulin in patients with enterovirus 71-associatedbrainstem encephalitis. J Clin Virol, 2006, 37(1): 47–52
doi: 10.1016/j.jcv.2006.05.009
|
|
Wang S M, Lei H Y, Huang M C, Wu J M, Chen C T, Wang J N, Wang J R, Liu C C. Therapeutic efficacy of milrinone inthe management of enterovirus 71-induced pulmonary edema. Pediatr Pulmonol, 2005, 39(3): 219–223
doi: 10.1002/ppul.20157
|
|
Chang L Y. Enterovirus 71 in Taiwan. Pediatr Neonatol, 2008, 49(4): 103–112
doi: 10.1016/S1875-9572(08)60023-6
|
|
Chen T C, Weng K F, Chang S C, Lin J Y, Huang P N, Shih S R. Development of antiviral agents for enteroviruses. J Antimicrob Chemother, 2008, 62(6): 1169–1173
doi: 10.1093/jac/dkn424
|
|
Pevear D C, Tull T M, Seipel M E, Groarke J M. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother, 1999, 43(9): 2109–2115
|
|
Shia K S, Li W T, Chang C M, Hsu M C, Chern J H, Leong M K, Tseng S N, Lee C C, Lee Y C, Chen S J, Peng K C, Tseng H Y, Chang Y L, Tai C L, Shih S R. Design, synthesis, and structure-activityrelationship of pyridyl imidazolidinones: a novel class of potentand selective human enterovirus 71 inhibitors. J Med Chem, 2002, 45(8): 1644–1655
doi: 10.1021/jm010536a
|
|
Li Z H, Li C M, Ling P, Shen F H, Chen S H, Liu C C, Yu C K. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viralreplication. J Infect Dis, 2008, 197(6): 854–857
doi: 10.1086/527326
|
|
Foo D G, Alonso S, Phoon M C, Ramachandran N P, Chow V T, Poh C L. Identification of neutralizinglinear epitopes from the VP1 capsid protein of Enterovirus 71 usingsynthetic peptides. Virus Res, 2007, 125(1): 61–68
doi: 10.1016/j.virusres.2006.12.005
|
|
Chen H L, Huang J Y, Chu T W, Tsai T C, Hung C M, Lin C C, Liu F C, Wang L C, Chen Y J, Lin M F, Chen C M. Expression of VP1 protein in the milk of transgenic mice:a potential oral vaccine protects against enterovirus 71 infection. Vaccine, 2008, 26(23): 2882–2889
doi: 10.1016/j.vaccine.2008.03.041
|
|
Ooi M H, Solomon T, Podin Y, Mohan A, Akin W, Yusuf M A, del Sel S, Kontol K M, Lai B F, Clear D, Chieng C H, Blake E, Perera D, Wong S C, Cardosa J. Evaluation of different clinical sample types in diagnosis of human enterovirus71-associated hand-foot-and-mouth disease. J Clin Microbiol, 2007, 45(6): 1858–1866
doi: 10.1128/JCM.01394-06
|
|
Perez-Velez C M, Anderson M S, Robinson C C, McFarland E J, Nix W A, Pallansch M A, Oberste M S, Glode M P. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis, 2007, 45(8): 950–957
doi: 10.1086/521895
|
|
Ooi M H, Wong S C, Mohan A, Podin Y, Perera D, Clear D, del Sel S, Chieng C H, Tio P H, Cardosa M J, Solomon T. Identification and validationof clinical predictors for the risk of neurological involvement inchildren with hand, foot, and mouth disease in Sarawak. BMC Infect Dis, 2009, 9: 3
doi: 10.1186/1471-2334-9-3
|
|
Chen K T, Chang H L, Wang S T, Cheng Y T, Yang J Y. Epidemiologic features ofhand-foot-mouth disease and herpangina caused by enterovirus 71 inTaiwan, 1998―2005. Pediatrics, 2007, 120(2): e244–252
doi: 10.1542/peds.2006-3331
|
|
Podin Y, Gias E L, Ong F, Leong Y W, Yee S F, Yusof M A, Perera D, Teo B, Wee T Y, Yao S C, Yao S K, Kiyu A, Arif M T, Cardosa M J. Sentinel surveillance for human enterovirus 71 in Sarawak,Malaysia: lessons from the first 7 years. BMC Public Health, 2006, 6: 180
doi: 10.1186/1471-2458-6-180
|
|
Chen S C, Chang H L, Yan T R, Cheng Y T, Chen K T. An eight-year study of epidemiologicfeatures of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg, 2007, 77(1): 188–191
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|